Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-02-06 @ 7:39 AM
Study NCT ID:
NCT06231693
Status:
TERMINATED
Last Update Posted:
2025-05-08
First Post:
2024-01-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords: